Biomarkers in triple negative breast cancer: A review

doi:10.5306/wjco.v6.i6.252

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (14413)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

1677

WORD

341

HTML

9169

Figures (1-1)

163

Tables (1-4)

201

Sum=11551

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1091

Download

1771

Sum=2862

Dec 10, 2015 (publication date) through Jun 15, 2024

Times Cited of This Article

Times Cited (90)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. Dec 10, 2015; 6(6): 252-263
Published online Dec 10, 2015. doi: 10.5306/wjco.v6.i6.252

Full Size Figure Download Figure

Figure 1 Mechanism of action of poly(ADP-ribose) polymerase-1 inhibitors in triple negative breast cancer. PARP-1: Poly(ADP-ribose) polymerase-1; SSB: Single strand breaks.

Citation: Yadav BS, Chanana P, Jhamb S. Biomarkers in triple negative breast cancer: A review. World J Clin Oncol 2015; 6(6): 252-263
URL: https://www.wjgnet.com/2218-4333/full/v6/i6/252.htm
DOI: https://dx.doi.org/10.5306/wjco.v6.i6.252